» Articles » PMID: 6620188

The Effect of Naloxone on Vasopressin Release from Rat Neurohypophysis Incubated in Vitro

Overview
Journal J Physiol
Specialty Physiology
Date 1983 Aug 1
PMID 6620188
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Rat posterior pituitaries were superfused in vitro and stimulated electrically. The concentrations of vasopressin in the superfusion medium were determined by radioimmunoassay. When the pulses were applied in 10 sec trains with 10 sec intervals, vasopressin release per pulse increased progressively over the frequency range of 3-12 pulses/sec applied within the trains. The release was blocked by addition of tetrodotoxin or by removal of calcium ions from the superfusion medium. The opiate antagonist naloxone 1 or 10 microM was introduced into the superfusion medium before a second period of stimulation and enhanced vasopressin release from neurointermediate lobes after phasic stimulation at 9 pulses/sec within the trains, when compared to controls. However, naloxone 10 microM had not effect on vasopressin release from isolated neural lobes (intermediate lobes removed), although the addition of camel beta-endorphin 2 microM inhibited vasopressin release in a naloxone-reversible manner. After continuous stimulation at a frequency of 13 Hz naloxone 10 microM did not influence the release of vasopressin from neurointermediate lobes. We conclude that the evoked release of vasopressin from the neurointermediate lobe is reduced by an endogenous opiate of intermediate lobe origin, possibly beta-endorphin. Appropriate stimulation conditions are necessary for this mechanism to function.

Citing Articles

The effects of opioids and opioid analogs on animal and human endocrine systems.

Vuong C, van Uum S, ODell L, Lutfy K, Friedman T Endocr Rev. 2009; 31(1):98-132.

PMID: 19903933 PMC: 2852206. DOI: 10.1210/er.2009-0009.


Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells.

Smalheiser N, Costa E, Guidotti A, Impagnatiello F, Auta J, Lacor P Proc Natl Acad Sci U S A. 2000; 97(3):1281-6.

PMID: 10655522 PMC: 15597. DOI: 10.1073/pnas.97.3.1281.


Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones?.

Nordmann J, Dayanithi G, Cazalis M Exp Brain Res. 1986; 61(3):560-6.

PMID: 3514253 DOI: 10.1007/BF00237581.


Opiate binding differentially associated with oxytocin and vasopressin nerve endings from porcine neurohypophyses.

Falke N, Martin R Exp Brain Res. 1988; 70(1):145-54.

PMID: 3402560 DOI: 10.1007/BF00271856.


Neurohypophysial opioids and oxytocin secretion: source of inhibitory opioids.

Bicknell R, Chapman C, Leng G Exp Brain Res. 1985; 60(1):192-6.

PMID: 2995108 DOI: 10.1007/BF00237032.


References
1.
Bower A, Hadley M, Hruby V . Biogenic amines and control of melanophore stimulating hormone release. Science. 1974; 184(4132):70-2. DOI: 10.1126/science.184.4132.70. View

2.
Simantov R, Snyder S . Opiate receptor binding in the pituitary gland. Brain Res. 1977; 124(1):178-84. DOI: 10.1016/0006-8993(77)90877-0. View

3.
Oliver C, Mical R, Porter J . Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk. Endocrinology. 1977; 101(2):598-604. DOI: 10.1210/endo-101-2-598. View

4.
Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C . beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science. 1977; 197(4311):1367-9. DOI: 10.1126/science.197601. View

5.
Bisset G, Chowdrey H, FELDBERG W . Release of vasopressin by enkephalin. Br J Pharmacol. 1978; 62(3):370-1. PMC: 1668152. DOI: 10.1111/j.1476-5381.1978.tb08472.x. View